# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001601485-25-000124
Filing Date
2025-11-13
Accepted
2025-11-13 16:08:50
Documents
83
Period of Report
2025-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | angn-20250930.htm iXBRL | 10-Q | 1083374
2 | EX-31.1 | elicio10-qxexhibit311.htm | EX-31.1 | 4385
3 | EX-31.2 | elicio10-qxexhibit312.htm | EX-31.2 | 4409
4 | EX-32.1 | elicio10-qxexhibit321.htm | EX-32.1 | 1624
5 | EX-32.2 | elicio10-qxexhibit322.htm | EX-32.2 | 1651
11 |  | elicio10-qxexhibit311001.jpg | GRAPHIC | 225028
12 |  | elicio10-qxexhibit311002.jpg | GRAPHIC | 66177
13 |  | elicio10-qxexhibit312001.jpg | GRAPHIC | 224747
14 |  | elicio10-qxexhibit312002.jpg | GRAPHIC | 68371
15 |  | elicio10-qxexhibit321001.jpg | GRAPHIC | 95943
16 |  | elicio10-qxexhibit322001.jpg | GRAPHIC | 98170
| Complete submission text file | 0001601485-25-000124.txt |  | 7710846

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | angn-20250930.xsd | EX-101.SCH | 52923
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | angn-20250930_cal.xml | EX-101.CAL | 61564
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | angn-20250930_def.xml | EX-101.DEF | 243705
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | angn-20250930_lab.xml | EX-101.LAB | 649484
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | angn-20250930_pre.xml | EX-101.PRE | 476800
86 | EXTRACTED XBRL INSTANCE DOCUMENT | angn-20250930_htm.xml | XML | 781828

Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Filer) CIK: 0001601485 (see all company filings)

EIN.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39990 | Film No.: 251478485
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)